SynOx Therapeutics
Broes Naeye is currently serving as the Chief Technology Officer at SynOx Therapeutics. Prior to this, Naeye held various positions at companies like Sanofi Genzyme and Ablynx, where they were involved in process characterisation and validation, design control of drug/device products, and coordination of GMP studies. Naeye's educational background includes a Licenciate in Pharmaceutical Sciences from Ghent University and completion of the Management Acceleration Programme at Vlerick Business School.
This person is not in any teams
This person is not in any offices
SynOx Therapeutics
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.